BICLUSTER_ID : UPREG-158
PATHOGENS /3/ : aeromonas caviae,streptococcus pyogenes,ehrlichia chaffeensis
TARGETS /25/ : LCN2, LCK, KIT, CD40, CD22, TNFRSF1B, HCK, VCAM1, ISG20, IFNG, CD86, GZMB, STAT1, C1QB, CCL8, LTB, C1QA, ITGB2, FCGR3A, IL2RG, IL1B, CASP1, ICAM1, TLR2, C1QC
Gene SetLeading Edge Genes
NETPATH IL 2 PATHWAY UPLCK, GBP1, TNFRSF1B, AIF1, NMI, SOCS3, IFI44, IFNG, FOS, GZMB, STAT1, KLF6, SP100, TNFSF10, CCR1, PTPRC, IL2RG, CCR2, SAMHD1, NKG7, IL1B, CCL3, ICAM1, CASP1, PBEF1, UPP1, MX1, GZMA
NCI IL12 2PATHWAYSTAT1, IL2RG, IL1B, CCL3, IFNG, FOS, GZMB, GZMA
NETPATH IL 4 PATHWAY DOWNLTB4R, STAT1, KIT, LTB, TNFSF10, GBP2, GJA4, NFKBIA, CHI3L1, ICAM1, TLR2, GZMA, MX1
NETPATH B CELL RECEPTOR PATHWAY DOWNNCF4, SLA, LCK, EVI2A, CXCL1, CD40, CD22, TNFSF10, TNFRSF1B, PTPRC, GBP2, NFKBIA, HCLS1, ISG20, IRF7, GZMA
NCI IL23PATHWAYSTAT1, CXCL1, IL18RAP, SOCS3, NFKBIA, IL1B, IFNG, CXCL9
NCI CLASSICAL ANTIBODY MEDIATED COMPLEMENT ACTIVATIONC1QB, C1QA, C1QC
SA MMP CYTOKINE CONNECTIONFCGR3A, CSF1, IL1B, TNFRSF1B
NCI IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELLIFITM1, VCAM1, KLRK1, TYROBP, CD40, ITGB2
NCI IL27PATHWAYGATA3, STAT1, IL1B, IFNG
NETPATH IL 9 PATHWAY UPSOCS3, LCN2, CCL3, GZMB, GZMA
NCI IL6 7PATHWAYSOCS3, STAT1, VAV1, FOS, HCK, LBP
ST INTERFERON GAMMA PATHWAYSTAT1, IFNG
NETPATH IL 3 PATHWAY UPSOCS3, IL1B, CCL3, CSF1, KIT, FOS, CCR1
NETPATH IL 5 PATHWAY UPBIRC3, NFKBIE, MAX, ITGB2, CCR1, CCL3, ICAM1, UPP1, MYD88, CASP4
NCI IL12 STAT4PATHWAYIL18RAP, IRF1, CD86, FOS, IFNG
NETPATH T CELL RECEPTOR PATHWAY DOWNIFITM1, CCR1, CCR2, NFKBIA, LSP1, CASP1, IRF7, ARHGDIB
NETPATH IL 7 PATHWAY UPKLRK1, CCL3, CXCL1, CCL8, CCL19
NETPATH IL 6 PATHWAY UPSTAT1, CADPS, MAP3K8, NMI, SOCS3, ZFP36, IRF1, FOS, MX1, SBNO2
GRAHAM CML QUIESCENT VS NORMAL DIVIDING DN
RASHI RESPONSE TO IONIZING RADIATION 6
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 16D UP
BOYAULT LIVER CANCER SUBCLASS G5 DN
ICHIBA GRAFT VERSUS HOST DISEASE D7 UP
BIOCARTA TCYTOTOXIC PATHWAY
TENEDINI MEGAKARYOCYTE MARKERS
LINDSTEDT DENDRITIC CELL MATURATION B
KRASNOSELSKAYA ILF3 TARGETS UP
LINDSTEDT DENDRITIC CELL MATURATION A
RADAEVA RESPONSE TO IFNA1 UP
MORI LARGE PRE BII LYMPHOCYTE DN
NCI CELL SURFACE INTERACTIONS AT THE VASCULAR WALL
WATANABE ULCERATIVE COLITIS WITH CANCER DN
BOWIE RESPONSE TO EXTRACELLULAR MATRIX
BIOCARTA NKT PATHWAY
BIOCARTA THELPER PATHWAY
BROWNE INTERFERON RESPONSIVE GENES
MORI MATURE B LYMPHOCYTE UP
HOFFMANN IMMATURE TO MATURE B LYMPHOCYTE UP
WILENSKY RESPONSE TO DARAPLADIB
REACTOME SIGNALING IN IMMUNE SYSTEM
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION ERYTHROCYTE UP
ROETH TERT TARGETS UP
HINATA NFKB TARGETS KERATINOCYTE UP
MILICIC FAMILIAL ADENOMATOUS POLYPOSIS DN
MARKEY RB1 ACUTE LOF UP
NCI FRUCTOSE 6 PHOSPHATE AND ATP REACT TO FORM FRUCTOSE 2 6 BISPHOSPHATE AND ADP
XU AKT1 TARGETS 6HR
NUYTTEN EZH2 TARGETS UP
DUTTA APOPTOSIS VIA NFKB
POOLA INVASIVE BREAST CANCER UP
DIRMEIER LMP1 RESPONSE EARLY
KEGG INTESTINAL IMMUNE NETWORK FOR IGA PRODUCTION
LIU VAV3 PROSTATE CARCINOGENESIS UP
NIELSEN SYNOVIAL SARCOMA DN
REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES
SEITZ NEOPLASTIC TRANSFORMATION BY 8P DELETION UP
BENNETT SYSTEMIC LUPUS ERYTHEMATOSUS
DAUER STAT3 TARGETS DN
RUTELLA RESPONSE TO HGF VS CSF2RB AND IL4 UP
NAKAYAMA SOFT TISSUE TUMORS PCA1 UP
LIAN LIPA TARGETS 6M
MCLACHLAN DENTAL CARIES UP
JAATINEN HEMATOPOIETIC STEM CELL DN
HOSHIDA LIVER CANCER SUBCLASS S1
FOSTER INFLAMMATORY RESPONSE LPS DN
LEE LIVER CANCER E2F1 UP
GAURNIER PSMD4 TARGETS
FINETTI BREAST CANCER KINOME GREEN
HELLER SILENCED BY METHYLATION UP
GRANDVAUX IFN RESPONSE NOT VIA IRF3
FARMER BREAST CANCER CLUSTER 1
ROETH TERT TARGETS DN
BOWIE RESPONSE TO TAMOXIFEN
PICCALUGA ANGIOIMMUNOBLASTIC LYMPHOMA UP
ICHIBA GRAFT VERSUS HOST DISEASE 35D UP
SMID BREAST CANCER LUMINAL B DN
ZHOU INFLAMMATORY RESPONSE LPS UP
NOJIMA SFRP2 TARGETS DN
TAVOR CEBPA TARGETS DN
LEE LIVER CANCER MYC E2F1 UP
REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL
NCI IL2 1PATHWAY
REACTOME TOLL LIKE RECEPTOR 4 CASCADE
VERHAAK AML WITH NPM1 MUTATED UP
GEISS RESPONSE TO DSRNA UP
GRAHAM CML DIVIDING VS NORMAL QUIESCENT DN
SATO SILENCED BY METHYLATION IN PANCREATIC CANCER 1
ZHAN MULTIPLE MYELOMA DN
BIOCARTA TCAPOPTOSIS PATHWAY
GRANDVAUX IRF3 TARGETS UP
ZHU CMV ALL UP
KEGG TOLL LIKE RECEPTOR SIGNALING PATHWAY
NATSUME RESPONSE TO INTERFERON BETA UP
LEE EARLY T LYMPHOCYTE DN
REACTOME CLASSICAL ANTIBODY MEDIATED COMPLEMENT ACTIVATION
KEGG CYTOKINE CYTOKINE RECEPTOR INTERACTION
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 0
KEGG PRIMARY IMMUNODEFICIENCY
ZHANG INTERFERON RESPONSE
AUJLA IL22 AND IL17A SIGNALING
STEARMAN TUMOR FIELD EFFECT UP
NCI TOLL LIKE RECEPTOR 4 TLR4 CASCADECD14, LBP, LY86
WALLACE PROSTATE CANCER RACE UP
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 10D UP
KIM LRRC3B TARGETS
WIELAND UP BY HBV INFECTION
ZHANG ANTIVIRAL RESPONSE TO RIBAVIRIN UP
RUTELLA RESPONSE TO CSF2RB AND IL4 DN
UROSEVIC RESPONSE TO IMIQUIMOD
CHIARADONNA NEOPLASTIC TRANSFORMATION KRAS CDC25 DN
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 3D UP
KEGG JAK STAT SIGNALING PATHWAY
FULCHER INFLAMMATORY RESPONSE LECTIN VS LPS DN
TSAI DNAJB4 TARGETS UP
DER IFN BETA RESPONSE UP
MORI PRE BI LYMPHOCYTE DN
KEGG NATURAL KILLER CELL MEDIATED CYTOTOXICITY
REACTOME INNATE IMMUNITY SIGNALING
DIAZ CHRONIC MEYLOGENOUS LEUKEMIA DN
BASSO CD40 SIGNALING UP
XU RESPONSE TO TRETINOIN AND NSC682994 UP
SOUCEK MYC TARGETS
BIOCARTA BLYMPHOCYTE PATHWAY
BIOCARTA DC PATHWAY
BOYLAN MULTIPLE MYELOMA C D DN
ZHAN MULTIPLE MYELOMA LB DN
MAHADEVAN RESPONSE TO MP470 UP
SMID BREAST CANCER NORMAL LIKE UP
KEGG AUTOIMMUNE THYROID DISEASE
FLECHNER BIOPSY KIDNEY TRANSPLANT REJECTED VS OK UP
SANA RESPONSE TO IFNG UP
LIANG SILENCED BY METHYLATION 2
DAUER STAT3 TARGETS UP
BIOCARTA CTL PATHWAY
KEGG LEISHMANIA INFECTION
DER IFN ALPHA RESPONSE UP
RUTELLA RESPONSE TO HGF DN
YU MYC TARGETS DN
BOYLAN MULTIPLE MYELOMA PCA1 UP
EINAV INTERFERON SIGNATURE IN CANCER
MCLACHLAN DENTAL CARIES DN
KEGG ALLOGRAFT REJECTION
SEKI INFLAMMATORY RESPONSE LPS UP
ZHANG RESPONSE TO IKK INHIBITOR AND TNF UP
ZHU CMV 8 HR UP
SANA TNF SIGNALING UP
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 8D UP
MOSERLE IFNA RESPONSE
LEE DIFFERENTIATING T LYMPHOCYTE
SCHUETZ BREAST CANCER DUCTAL INVASIVE UP
FOSTER INFLAMMATORY RESPONSE LPS UP
ROSS AML WITH CBFB MYH11 FUSION
BIOCARTA ASBCELL PATHWAY
RODWELL AGING KIDNEY UP
CASTELLANO NRAS TARGETS UP
LIAN LIPA TARGETS 3M
KEGG CHEMOKINE SIGNALING PATHWAY
KEGG CYTOSOLIC DNA SENSING PATHWAY
BIOCARTA GRANULOCYTES PATHWAY
JISON SICKLE CELL DISEASE UP
VALK AML CLUSTER 5
MORI IMMATURE B LYMPHOCYTE UP
CHIANG LIVER CANCER SUBCLASS INTERFERON UP
HESS TARGETS OF HOXA9 AND MEIS1 DN
GRAHAM CML QUIESCENT VS NORMAL DIVIDING UP
ZHAN MULTIPLE MYELOMA HP UP
NETPATH IL 4 PATHWAY
LU IL4 SIGNALING
BERTUCCI MEDULLARY VS DUCTAL BREAST CANCER UP
Color legend
q-value10.20.050.010.0010.0001
Color
TABLE OF Q-VALUES
streptococcus pyogenesaeromonas caviaehrlichia chaffeensis libertyGeneSet Name
0.01602 0.07215 0.01786NETPATH_IL_2_PATHWAY_UP
0.00000 0.00545 0.00032NCI_IL12_2PATHWAY
0.00471 0.01190 0.00340NETPATH_IL_4_PATHWAY_DOWN
0.03148 0.15420 0.01567NETPATH_B_CELL_RECEPTOR_PATHWAY_DOWN
0.00014 0.00704 0.00440NCI_IL23PATHWAY
0.02568 0.01860 0.06387NCI_CLASSICAL_ANTIBODY_MEDIATED_COMPLEMENT_ACTIVATION
0.02244 0.02492 0.00029SA_MMP_CYTOKINE_CONNECTION
0.00000 0.01112 0.00065NCI_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL
0.00027 0.00317 0.03237NCI_IL27PATHWAY
0.00011 0.07320 0.00207NETPATH_IL_9_PATHWAY_UP
0.00000 0.07318 0.00014NCI_IL6_7PATHWAY
0.02104 0.13280 0.03205ST_INTERFERON_GAMMA_PATHWAY
0.00095 0.00216 0.00030NETPATH_IL_3_PATHWAY_UP
0.03974 0.07327 0.05924NETPATH_IL_5_PATHWAY_UP
0.00112 0.14161 0.00901NCI_IL12_STAT4PATHWAY
0.13300 0.16575 0.01205NETPATH_T_CELL_RECEPTOR_PATHWAY_DOWN
0.04416 0.16616 0.00005NETPATH_IL_7_PATHWAY_UP
0.00001 0.10211 0.00150NETPATH_IL_6_PATHWAY_UP
0.02313 0.05537 0.08806GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN
0.00203 0.01533 0.00001RASHI_RESPONSE_TO_IONIZING_RADIATION_6
0.08562 0.00143 0.00011TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP
0.00000 0.00015 0.00069BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN
0.00000 0.00000 0.00000ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP
0.00569 0.03039 0.07177BIOCARTA_TCYTOTOXIC_PATHWAY
0.00784 0.07889 0.00032TENEDINI_MEGAKARYOCYTE_MARKERS
0.02304 0.00053 0.02223LINDSTEDT_DENDRITIC_CELL_MATURATION_B
0.00396 0.00214 0.00644KRASNOSELSKAYA_ILF3_TARGETS_UP
0.00032 0.00124 0.00000LINDSTEDT_DENDRITIC_CELL_MATURATION_A
0.00000 0.00000 0.00009RADAEVA_RESPONSE_TO_IFNA1_UP
0.00399 0.00001 0.00000MORI_LARGE_PRE_BII_LYMPHOCYTE_DN
0.17774 0.04637 0.09147NCI_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL
0.02583 0.01527 0.00550WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_DN
0.00020 0.00058 0.00412BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX
0.05474 0.18798 0.00035BIOCARTA_NKT_PATHWAY
0.00252 0.04360 0.03572BIOCARTA_THELPER_PATHWAY
0.00000 0.00000 0.00000BROWNE_INTERFERON_RESPONSIVE_GENES
0.03190 0.01086 0.00000MORI_MATURE_B_LYMPHOCYTE_UP
0.01390 0.02949 0.03334HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP
0.00009 0.00819 0.00000WILENSKY_RESPONSE_TO_DARAPLADIB
0.00018 0.00615 0.00032REACTOME_SIGNALING_IN_IMMUNE_SYSTEM
0.13253 0.16527 0.06656TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP
0.00062 0.00363 0.00140ROETH_TERT_TARGETS_UP
0.05930 0.06206 0.00058HINATA_NFKB_TARGETS_KERATINOCYTE_UP
0.19363 0.15437 0.06439MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_DN
0.00000 0.00000 0.00000MARKEY_RB1_ACUTE_LOF_UP
0.15417 0.13262 0.14692NCI_FRUCTOSE_6_PHOSPHATE_AND_ATP_REACT_TO_FORM_FRUCTOSE_2_6_BISPHOSPHATE_AND_ADP
0.01569 0.01113 0.00156XU_AKT1_TARGETS_6HR
0.10005 0.07444 0.11368NUYTTEN_EZH2_TARGETS_UP
0.02575 0.05340 0.00023DUTTA_APOPTOSIS_VIA_NFKB
0.00003 0.00390 0.00000POOLA_INVASIVE_BREAST_CANCER_UP
0.00616 0.00564 0.00342DIRMEIER_LMP1_RESPONSE_EARLY
0.00394 0.07861 0.08853KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION
0.00000 0.00001 0.00000LIU_VAV3_PROSTATE_CARCINOGENESIS_UP
0.00113 0.08616 0.18413NIELSEN_SYNOVIAL_SARCOMA_DN
0.00007 0.00008 0.00023REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES
0.00000 0.00003 0.00181SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP
0.00004 0.00041 0.00011BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS
0.00003 0.00000 0.00295DAUER_STAT3_TARGETS_DN
0.18510 0.11676 0.00908RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP
0.00012 0.00001 0.00000NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP
0.00004 0.01871 0.00000LIAN_LIPA_TARGETS_6M
0.00000 0.00003 0.00000MCLACHLAN_DENTAL_CARIES_UP
0.00039 0.01353 0.00000JAATINEN_HEMATOPOIETIC_STEM_CELL_DN
0.00019 0.09158 0.00018HOSHIDA_LIVER_CANCER_SUBCLASS_S1
0.00568 0.00001 0.00078FOSTER_INFLAMMATORY_RESPONSE_LPS_DN
0.01561 0.01675 0.00413LEE_LIVER_CANCER_E2F1_UP
0.00000 0.00001 0.00000GAURNIER_PSMD4_TARGETS
0.02716 0.09923 0.01670FINETTI_BREAST_CANCER_KINOME_GREEN
0.00113 0.00206 0.00000HELLER_SILENCED_BY_METHYLATION_UP
0.00000 0.00003 0.00730GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3
0.00000 0.00001 0.00000FARMER_BREAST_CANCER_CLUSTER_1
0.04188 0.02252 0.00954ROETH_TERT_TARGETS_DN
0.00016 0.00004 0.00007BOWIE_RESPONSE_TO_TAMOXIFEN
0.08503 0.04189 0.19454PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP
0.00000 0.00000 0.00000ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP
0.05508 0.08643 0.00253SMID_BREAST_CANCER_LUMINAL_B_DN
0.06782 0.01590 0.03822ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
0.01391 0.00332 0.04856NOJIMA_SFRP2_TARGETS_DN
0.16079 0.18687 0.13916TAVOR_CEBPA_TARGETS_DN
0.01825 0.01790 0.00544LEE_LIVER_CANCER_MYC_E2F1_UP
0.00000 0.00222 0.00001REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL
0.05407 0.03816 0.18437NCI_IL2_1PATHWAY
0.03170 0.04826 0.00646REACTOME_TOLL_LIKE_RECEPTOR_4_CASCADE
0.01128 0.08932 0.00000VERHAAK_AML_WITH_NPM1_MUTATED_UP
0.01876 0.00364 0.01274GEISS_RESPONSE_TO_DSRNA_UP
0.19908 0.00399 0.00118GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN
0.01687 0.08380 0.17607SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1
0.00392 0.04491 0.00049ZHAN_MULTIPLE_MYELOMA_DN
0.02578 0.19522 0.10029BIOCARTA_TCAPOPTOSIS_PATHWAY
0.00549 0.06268 0.00053GRANDVAUX_IRF3_TARGETS_UP
0.06342 0.14609 0.06440ZHU_CMV_ALL_UP
0.00011 0.00443 0.00866KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.11227 0.04204 0.11926NATSUME_RESPONSE_TO_INTERFERON_BETA_UP
0.05939 0.18592 0.00816LEE_EARLY_T_LYMPHOCYTE_DN
0.02352 0.00510 0.02957REACTOME_CLASSICAL_ANTIBODY_MEDIATED_COMPLEMENT_ACTIVATION
0.00010 0.01697 0.00077KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION
0.07680 0.00084 0.17885YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0
0.00955 0.00602 0.02818KEGG_PRIMARY_IMMUNODEFICIENCY
0.00000 0.00003 0.00000ZHANG_INTERFERON_RESPONSE
0.02059 0.01459 0.12142AUJLA_IL22_AND_IL17A_SIGNALING
0.02314 0.00919 0.00132STEARMAN_TUMOR_FIELD_EFFECT_UP
0.15664 0.01926 0.02298NCI_TOLL_LIKE_RECEPTOR_4__TLR4__CASCADE
0.00000 0.00000 0.00000WALLACE_PROSTATE_CANCER_RACE_UP
0.00854 0.00001 0.00209TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP
0.00000 0.00000 0.00144KIM_LRRC3B_TARGETS
0.00000 0.00000 0.00000WIELAND_UP_BY_HBV_INFECTION
0.00011 0.02237 0.04794ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP
0.02986 0.02718 0.00000RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN
0.00001 0.00001 0.00027UROSEVIC_RESPONSE_TO_IMIQUIMOD
0.01836 0.00603 0.00580CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN
0.00000 0.00000 0.00004TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP
0.00074 0.00316 0.18395KEGG_JAK_STAT_SIGNALING_PATHWAY
0.00016 0.00001 0.00000FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN
0.00073 0.01036 0.00743TSAI_DNAJB4_TARGETS_UP
0.00032 0.00003 0.08872DER_IFN_BETA_RESPONSE_UP
0.06972 0.00014 0.00033MORI_PRE_BI_LYMPHOCYTE_DN
0.02643 0.00192 0.00017KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY
0.00979 0.06199 0.14075REACTOME_INNATE_IMMUNITY_SIGNALING
0.00046 0.09215 0.00000DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN
0.00023 0.00110 0.00000BASSO_CD40_SIGNALING_UP
0.00327 0.01774 0.00430XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP
0.00021 0.00169 0.00038SOUCEK_MYC_TARGETS
0.02720 0.04205 0.00468BIOCARTA_BLYMPHOCYTE_PATHWAY
0.01251 0.01876 0.00817BIOCARTA_DC_PATHWAY
0.00075 0.00178 0.00000BOYLAN_MULTIPLE_MYELOMA_C_D_DN
0.00000 0.00000 0.00081ZHAN_MULTIPLE_MYELOMA_LB_DN
0.01593 0.00240 0.00131MAHADEVAN_RESPONSE_TO_MP470_UP
0.00464 0.00209 0.00000SMID_BREAST_CANCER_NORMAL_LIKE_UP
0.00071 0.04468 0.08016KEGG_AUTOIMMUNE_THYROID_DISEASE
0.00000 0.00000 0.00000FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP
0.00000 0.00000 0.00245SANA_RESPONSE_TO_IFNG_UP
0.00099 0.00001 0.00000LIANG_SILENCED_BY_METHYLATION_2
0.00038 0.05120 0.06350DAUER_STAT3_TARGETS_UP
0.00074 0.03157 0.00719BIOCARTA_CTL_PATHWAY
0.00061 0.05933 0.00000KEGG_LEISHMANIA_INFECTION
0.00000 0.00000 0.09673DER_IFN_ALPHA_RESPONSE_UP
0.15257 0.04351 0.00008RUTELLA_RESPONSE_TO_HGF_DN
0.02906 0.00147 0.02696YU_MYC_TARGETS_DN
0.00004 0.00286 0.00000BOYLAN_MULTIPLE_MYELOMA_PCA1_UP
0.00000 0.00000 0.00290EINAV_INTERFERON_SIGNATURE_IN_CANCER
0.00000 0.00003 0.00000MCLACHLAN_DENTAL_CARIES_DN
0.03176 0.01652 0.00019KEGG_ALLOGRAFT_REJECTION
0.00000 0.00002 0.00000SEKI_INFLAMMATORY_RESPONSE_LPS_UP
0.00019 0.00001 0.00059ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
0.00367 0.00058 0.00029ZHU_CMV_8_HR_UP
0.00000 0.00000 0.00008SANA_TNF_SIGNALING_UP
0.00957 0.00109 0.00351TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP
0.00000 0.00000 0.00000MOSERLE_IFNA_RESPONSE
0.01087 0.00751 0.00000LEE_DIFFERENTIATING_T_LYMPHOCYTE
0.11584 0.10206 0.00142SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP
0.00000 0.01920 0.00000FOSTER_INFLAMMATORY_RESPONSE_LPS_UP
0.00096 0.04328 0.00397ROSS_AML_WITH_CBFB_MYH11_FUSION
0.18436 0.04179 0.00506BIOCARTA_ASBCELL_PATHWAY
0.00000 0.00002 0.00000RODWELL_AGING_KIDNEY_UP
0.00217 0.02086 0.00715CASTELLANO_NRAS_TARGETS_UP
0.00004 0.04935 0.00000LIAN_LIPA_TARGETS_3M
0.01866 0.01801 0.00209KEGG_CHEMOKINE_SIGNALING_PATHWAY
0.04007 0.00700 0.05665KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY
0.01558 0.04491 0.00128BIOCARTA_GRANULOCYTES_PATHWAY
0.00066 0.00632 0.00099JISON_SICKLE_CELL_DISEASE_UP
0.10714 0.00620 0.00142VALK_AML_CLUSTER_5
0.00223 0.00218 0.00000MORI_IMMATURE_B_LYMPHOCYTE_UP
0.00960 0.13180 0.00033CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP
0.00000 0.01035 0.00000HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN
0.05507 0.09323 0.00033GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.16093 0.06325 0.05935ZHAN_MULTIPLE_MYELOMA_HP_UP
0.13277 0.12658 0.02219NETPATH_IL_4_PATHWAY
0.14418 0.01920 0.00508LU_IL4_SIGNALING
0.01025 0.00108 0.03067BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP